Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment

Interleukin-33 (IL-33) was recently shown to be involved in the inflammatory tumour microenvironment and the progression of colorectal cancer (CRC). We report here that the expression level of sST2, a soluble form of the IL-33 receptor (ST2L), is inversely associated with the malignant growth of CRC...

Descripción completa

Detalles Bibliográficos
Autores principales: Akimoto, Miho, Maruyama, Riruke, Takamaru, Hiroyuki, Ochiya, Takahiro, Takenaga, Keizo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123057/
https://www.ncbi.nlm.nih.gov/pubmed/27882929
http://dx.doi.org/10.1038/ncomms13589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123057/
https://www.ncbi.nlm.nih.gov/pubmed/27882929
http://dx.doi.org/10.1038/ncomms13589

Ejemplares similares